Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of piracetam in preventing delirium in ICU patients
IRCT20240105060618N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of piracetam in delirium, sponsored by Tehran University of Medical Sciences. Started Apr 2024; status: completed.
02
Drugs
piracetam
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20240105060618N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240105060618N1.